Literature DB >> 29610183

Craniosynostosis as the Presenting Feature of X-linked Hypophosphatemic Rickets.

Janaki D Vakharia1,2, Kristal Matlock3,4, Helena O Taylor5,6, Philippe F Backeljauw3,4, Lisa Swartz Topor7,8.   

Abstract

Craniosynostosis is the premature closure of cranial sutures. Primary, or congenital, craniosynostosis is often sporadic but may be associated with genetic or chromosomal abnormalities. Secondary craniosynostosis presents after gestation, and can occur in metabolic bone diseases, including rickets. We describe the first reported cases of primary craniosynostosis in 2 unrelated, term infants with X-linked hypophosphatemic rickets (XLH). The diagnosis of XLH in both patients was confirmed by genetic testing. At the time craniosynostosis was detected, the patient in the first case did not have any other clinical features of XLH. The second patient developed clinical findings of craniosynostosis, followed by rickets. These are the earliest reported cases of craniosynostosis in XLH and demonstrate that craniosynostosis may be a presenting feature of this disease.
Copyright © 2018 by the American Academy of Pediatrics.

Entities:  

Mesh:

Year:  2018        PMID: 29610183     DOI: 10.1542/peds.2017-2522

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  8 in total

1.  The first Korean case report with scaphocephaly as the initial sign of X-linked hypophosphatemic rickets.

Authors:  Keun Soo Lee; Bo Lyun Lee
Journal:  Childs Nerv Syst       Date:  2019-01-06       Impact factor: 1.475

2.  Risk of cardiovascular involvement in pediatric patients with X-linked hypophosphatemia.

Authors:  Olaya Hernández-Frías; Helena Gil-Peña; José M Pérez-Roldán; Susana González-Sanchez; Gema Ariceta; Sara Chocrón; Reyner Loza; Francisco de la Cerda Ojeda; Leire Madariaga; Inés Vergara; Marta Fernández-Fernández; Susana Ferrando-Monleón; Montserrat Antón-Gamero; Ángeles Fernández-Maseda; M Isabel Luis-Yanes; Fernando Santos
Journal:  Pediatr Nephrol       Date:  2019-01-04       Impact factor: 3.714

3.  Long-term outcomes for Asian patients with X-linked hypophosphataemia: rationale and design of the SUNFLOWER longitudinal, observational cohort study.

Authors:  Takuo Kubota; Seiji Fukumoto; Hae Il Cheong; Toshimi Michigami; Noriyuki Namba; Nobuaki Ito; Shin Tokunaga; Yoshimi Gibbs; Keiichi Ozono
Journal:  BMJ Open       Date:  2020-06-29       Impact factor: 2.692

Review 4.  Dental-craniofacial manifestation and treatment of rare diseases.

Authors:  En Luo; Hanghang Liu; Qiucheng Zhao; Bing Shi; Qianming Chen
Journal:  Int J Oral Sci       Date:  2019-02-20       Impact factor: 6.344

Review 5.  X-Linked Hypophosphatemic Rickets: Multisystemic Disorder in Children Requiring Multidisciplinary Management.

Authors:  Giampiero Igli Baroncelli; Stefano Mora
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-06       Impact factor: 5.555

6.  Sustained Efficacy and Safety of Burosumab, a Monoclonal Antibody to FGF23, in Children With X-Linked Hypophosphatemia.

Authors:  Agnès Linglart; Erik A Imel; Michael P Whyte; Anthony A Portale; Wolfgang Högler; Annemieke M Boot; Raja Padidela; William Van't Hoff; Gary S Gottesman; Angel Chen; Alison Skrinar; Mary Scott Roberts; Thomas O Carpenter
Journal:  J Clin Endocrinol Metab       Date:  2022-02-17       Impact factor: 5.958

Review 7.  Rickets in Children: An Update.

Authors:  Cristina Gentile; Francesco Chiarelli
Journal:  Biomedicines       Date:  2021-06-27

8.  An Expert Perspective on Phosphate Dysregulation With a Focus on Chronic Hypophosphatemia.

Authors:  Fahad Aljuraibah; Justine Bacchetta; Maria Luisa Brandi; Pablo Florenzano; Muhammad K Javaid; Outimaija Mäkitie; Adalbert Raimann; Mariano Rodriguez; Heide Siggelkow; Dov Tiosano; Marc Vervloet; Carsten A Wagner
Journal:  J Bone Miner Res       Date:  2021-12-23       Impact factor: 6.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.